SMi Group Announce Vitalograph And Aerocrine As Sponsors Of Asthma & COPD

Date: Apr-03-2013SMi Group is pleased to announce Vitalograph and Aerocrine as sponsors of the 9th instalment in the Asthma series, taking place on 15th and 16th April, London.

"2013 is an exciting year for Vitalograph as we celebrate our 50th anniversary. We are particularly looking forward to the forthcoming SMI Asthma & COPD Conference where we will showcase our latest products and services including the new Compact workstation."
Jonathan Pritchard, Business Development Manager, Clinical Trials, Vitalograph Ltd.

Confirmed attendees include Astra Zeneca, Novartis, Pulmagen, Medlmmune, GSK, 3M Health Care, F. Hoffmann-La Roche Ltd, AlgiPharma, Glenmark, Fidelta, Almirall, Biomedical Systems, Aptar Pharma, Napp, Paediatric Care Centre, Teva, Imperial College, Roche plus many more...

The 9th Annual Asthma & COPD event comes at a perfect time to discuss latest developments and challenges alongside strategies to improve patient outcomes. Delegates will be able to learn the challenges and successes of peers and apply this knowledge to businesses, gaining the most efficient ways to move forward.

To learn more about the event click here or email fbegum@smi-online.co.uk for a free brochure.

Asthma & COPD 15th & 16th April, Copthorne Tara Hotel, London.

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.